GLP-1 analogue liraglutide as adjunct treatment in diabetes type 2 after failed bariatric/metabolic surgery
Open accessAbstract
Obesity with its negative effect on health (1) has become a major challenge to physicians as well as surgeons throughout the world. Today more than 650 million people worldwide are obese (1). To the physician, the individuals’ positive energy balance with a greater energy intake than expenditure means an increased rate of diabetes type 2 and insulin resistance along with debilitating complications such as hypertension, stroke and cardiac disease, sleep respiratory disorders including sleep disturbance, blood lipid abnormalities and non-alcoholic fatty liver disease. To the surgeon, the problem mainly deals with the stigmatizing body composition, excessive accumulation of adipose tissue and immobility. Furthermore, there is a link to a number of cancers, such as endometrium, breast, ovary, prostate, liver, gallbladder, kidney, and colorectal cancer.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Weight loss with liraglutide in clinical trials was of lesser magnitude and appeared to plateau earlier (at 20 or 40 weeks) than with semaglutide in the present trial (at 60-68 weeks).
“weight loss with liraglutide in clinical trials was of lesser magnitude and appeared to plateau earlier (at 20 weeks 31 or 40 weeks 30 ) than with semaglutide in the present trial (at 60-68 weeks).”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
The role of leptin and ghrelin in the regulation of food intake and body weight in humans: a review
Klok, M. D., Jakobsdottir, S., & Drent, M. L. (2007) · Obesity Reviews · doi:10.1111/j.1467-789x.2006.00270.x · Cited by 1,442 · see citing works
Gloy, V. L., Briel, M., Bhatt, D. L., Kashyap, S. R., Schauer, P. R., Mingrone, G., Bucher, H. C., & Nordmann, A. J. (2013) · BMJ · doi:10.1136/bmj.f5934 · Cited by 1,351 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Rubino, D., Abrahamsson, N., Davies, M., Hesse, D., Greenway, F. L., Jensen, C., Lingvay, I., Mosenzon, O., Rosenstock, J., Rubio, M. A., et al. (2021) · JAMA · doi:10.1001/jama.2021.3224 · Cited by 1,444 · see citing works
- Authors
- Hellström, P. M.
- Affiliations
- Uppsala University (SE)
- Corresponding author
- Hellström, Per M.
- ORCID
- Hellström, Per M.
- Venue
- Annals of Translational Medicine
- Publisher
- AME Publishing Company
- Published
- 2019-09
- Volume
- 7
- Issue
- S6
- Pages
- S240-S240
- ISSN
- 2305-5839 (ISSN-L)
- 2305-5847
- PMC
- PMC6789358
- OpenAlex
- W2971372343
- Cited by
- 6
- References
- 2
- Citations by year
- 2024: 1 · 2023: 3 · 2022: 1 · 2021: 1
- FWCI
- 0.48
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Annals of Translational Medicine (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- liraglutide, GLP-1 receptor agonists, type 2 diabetes, obesity, metabolic surgery, adjunctive therapy, insulin resistance
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
